186 related articles for article (PubMed ID: 35593925)
21. Liver SULmean at FDG PET/CT: interreader agreement and impact of placement of volume of interest.
Viner M; Mercier G; Hao F; Malladi A; Subramaniam RM
Radiology; 2013 May; 267(2):596-601. PubMed ID: 23297330
[TBL] [Abstract][Full Text] [Related]
22. Phantom-based acquisition time and image reconstruction parameter optimisation for oncologic FDG PET/CT examinations using a digital system.
Fragoso Costa P; Jentzen W; Brahmer A; Mavroeidi IA; Zarrad F; Umutlu L; Fendler WP; Rischpler C; Herrmann K; Conti M; Seifert R; Sraieb M; Weber M; Kersting D
BMC Cancer; 2022 Aug; 22(1):899. PubMed ID: 35978274
[TBL] [Abstract][Full Text] [Related]
23. Two-time-point FDG PET/CT: liver SULmean repeatability.
Tahari AK; Paidpally V; Chirindel A; Wahl RL; Subramaniam RM
AJR Am J Roentgenol; 2015 Feb; 204(2):402-7. PubMed ID: 25615764
[TBL] [Abstract][Full Text] [Related]
24. Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the Biograph Vision Quadra with the Biograph Vision PET/CT.
Alberts I; Hünermund JN; Prenosil G; Mingels C; Bohn KP; Viscione M; Sari H; Vollnberg B; Shi K; Afshar-Oromieh A; Rominger A
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2395-2404. PubMed ID: 33797596
[TBL] [Abstract][Full Text] [Related]
25. Semi-automated histogram analysis of normal bone marrow using
Satoh Y; Funayama S; Onishi H; Kirito K
BMC Med Imaging; 2022 Feb; 22(1):31. PubMed ID: 35197004
[TBL] [Abstract][Full Text] [Related]
26. Liver standardized uptake value corrected for lean body mass at FDG PET/CT: effect of FDG uptake time.
Chirindel A; Alluri KC; Tahari AK; Chaudhry M; Wahl RL; Lodge MA; Subramaniam RM
Clin Nucl Med; 2015 Jan; 40(1):e17-22. PubMed ID: 24873794
[TBL] [Abstract][Full Text] [Related]
27. Dose Optimization in
Rana N; Kaur M; Singh H; Mittal BR
J Nucl Med Technol; 2021 Mar; 49(1):49-53. PubMed ID: 32887760
[TBL] [Abstract][Full Text] [Related]
28. Artificial intelligence enables whole-body positron emission tomography scans with minimal radiation exposure.
Wang YJ; Baratto L; Hawk KE; Theruvath AJ; Pribnow A; Thakor AS; Gatidis S; Lu R; Gummidipundi SE; Garcia-Diaz J; Rubin D; Daldrup-Link HE
Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2771-2781. PubMed ID: 33527176
[TBL] [Abstract][Full Text] [Related]
29. Treatment response assessment in [
Dolci C; Spadavecchia C; Crivellaro C; De Ponti E; Todde S; Morzenti S; Turolla EA; Crespi A; Guerra L; Landoni C
Phys Med; 2019 Jan; 57():177-182. PubMed ID: 30738523
[TBL] [Abstract][Full Text] [Related]
30. Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.
Hartung-Knemeyer V; Beiderwellen KJ; Buchbender C; Kuehl H; Lauenstein TC; Bockisch A; Poeppel TD
Invest Radiol; 2013 May; 48(5):290-4. PubMed ID: 23399811
[TBL] [Abstract][Full Text] [Related]
31. Total-body
Hu P; Zhang Y; Yu H; Chen S; Tan H; Qi C; Dong Y; Wang Y; Deng Z; Shi H
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2384-2394. PubMed ID: 33866409
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic performance of total-body
Hu Y; Liu G; Yu H; Gu J; Shi H
Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3538-3546. PubMed ID: 35344063
[TBL] [Abstract][Full Text] [Related]
33. How fast can we scan patients with modern (digital) PET/CT systems?
Lasnon C; Coudrais N; Houdu B; Nganoa C; Salomon T; Enilorac B; Aide N
Eur J Radiol; 2020 Aug; 129():109144. PubMed ID: 32593080
[TBL] [Abstract][Full Text] [Related]
34. The effect of acquisition time on visual and semi-quantitative analysis of F-18 FDG-PET studies in patients with head and neck cancer.
Goethals I; D'Asseler Y; Dobbeleir A; Deblaere K; Ham H
Nucl Med Commun; 2010 Mar; 31(3):227-31. PubMed ID: 20023593
[TBL] [Abstract][Full Text] [Related]
35.
Sibille L; Seifert R; Avramovic N; Vehren T; Spottiswoode B; Zuehlsdorff S; Schäfers M
Radiology; 2020 Feb; 294(2):445-452. PubMed ID: 31821122
[TBL] [Abstract][Full Text] [Related]
36. The impact of acquisition time on image quality in whole-body 18F-FDG PET/CT for cancer staging.
Hausmann D; Dinter DJ; Sadick M; Brade J; Schoenberg SO; Büsing K
J Nucl Med Technol; 2012 Dec; 40(4):255-8. PubMed ID: 23071347
[TBL] [Abstract][Full Text] [Related]
37. Predicting the Recurrence of Hepatocellular Carcinoma after Primary Living Donor Liver Transplantation Using Metabolic Parameters Obtained from
Kang S; Kim JD; Choi DL; Choi B
J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054048
[TBL] [Abstract][Full Text] [Related]
38. Investigating ultra-low-dose total-body [18F]-FDG PET/CT in colorectal cancer: initial experience.
Tan H; Cai D; Sui X; Qi C; Mao W; Zhang Y; Liu G; Yu H; Chen S; Hu P; Gu J; Shi H
Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):1002-1011. PubMed ID: 34462790
[TBL] [Abstract][Full Text] [Related]
39. Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer.
Tan H; Sui X; Yin H; Yu H; Gu Y; Chen S; Hu P; Mao W; Shi H
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1966-1975. PubMed ID: 33244618
[TBL] [Abstract][Full Text] [Related]
40. Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients.
Kramer GM; Frings V; Hoetjes N; Hoekstra OS; Smit EF; de Langen AJ; Boellaard R
J Nucl Med; 2016 Sep; 57(9):1343-9. PubMed ID: 27103020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
